布普伦诺芬的药物基因组学 - 一个叙述性回顾
Lakshmi Aravindan1, Sanjana Velu2, Inesh Sivam3
1Department of Biosciences, Rice University, Houston, TX, USA.
Pharmacogenomics
|September 5, 2025
概括
基因变异影响布普伦诺芬
科学领域:
- 药物基因组学
- 神经科学
- 临床药理学
背景情况:
- 布普伦诺芬是治疗阿片类药物使用障碍 (OUD) 和控制疼痛的重要药物.
- 它的独特特性,包括更长的作用时间和降低呼吸抑制的风险,使其优于其他阿片类药物.
- 个体对布普伦诺芬的反应可能有很大差异.
研究的目的:
- 对影响布诺芬药理动力学和药理动力学的基因变异进行现有文献审查.
- 确定特定的基因及其在改变布普伦诺芬代谢和临床效应中的潜在作用.
- 根据遗传特征评估目前针对个性化布诺芬治疗的证据.
主要方法:
- 在像PubMed这样的数据库中进行全面的文献搜索.
- 对与布诺芬相关的遗传多态性研究的分析.
- 专注于参与药物代谢 (例如CYP3A4,UGT2B7) 和受体结合 (例如OPRM1) 的基因.
主要成果:
- CYP3A4,UGT2B7,OPRM1,PDYN和SLC6A3的遗传变异可能会影响布诺芬的代谢和患者的反应.
- 强有力的证据将CYP3A4和UGT2B7的多态性与布普伦诺芬剂量要求和治疗OUD和疼痛的疗效的变化联系在一起.
- 个体对布普伦诺芬的反应受到遗传变异的显著影响.
结论:
- 遗传因素在决定个人对布普伦诺芬的反应方面起着至关重要的作用.
- 目前的证据不足以支持用于个性化布普伦诺芬剂量的常规临床测试.
- 未来的研究应集中在基于遗传特征的布普伦诺芬个性化风险预测和剂量策略的验证上.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
293
Drug Biotransformation: Overview
2.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.9K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
419
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
419
Factors Affecting Drug Biotransformation: Biological
230
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
230
Drug Abuse and Addiction: Pharmacological Phenomena
653
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
653
Factors Affecting Drug Response: Overview
2.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.3K


